TILS.L Regulatory News (TILS)

21 Nov 2007 14:01

ReGen Therapeutics PLC21 November 2007 ReGen Therapeutics Plc 21 November 2007 ReGen Therapeutics Plc DIRECTORS' SHAREHOLDINGS London, UK - 21 November, 2007: ReGen Therapeutics Plc (the "Company") announcesthat it has today received notifications from three of its directors that theyhave acquired additional ordinary shares in the Company. Mr Percy Lomax hasacquired 12,250 ordinary shares at 40p per share and now holds 38,487 ordinaryshares representing 0.375% of the current issued share capital of the Company.Mr Martin Small has acquired 12,000 ordinary shares at 40p per share and nowholds 45,820 ordinary shares representing 0.447% of the current issued sharecapital of the Company. Dr Peter Garrod has acquired 10,000 ordinary shares at41p per share and now holds 757,500 ordinary shares representing 7.38% of thecurrent issued share capital of the Company. Executive Chairman Percy Lomax commented "These purchases demonstrate theDirectors confidence in the Company and its future." For further information, please contact: Andrew MarshallGreycoat CommunicationsTel No 020 7960 6007 Percy Lomax - Executive ChairmanReGen Therapeutics PlcTel No 020 7153 4920Direct No 020 8504 2156 Roland CornishBeaumont Cornish LimitedTel No 020 7628 3396 Nick BealerKing & Shaxson Capital LimitedTel No 020 7426 5986 This information is provided by RNS The company news service from the London Stock Exchange